- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02101450
Extra-abdominal Removal of Placenta During CS
Evaluation of the Effects of Extra-abdominal Removal of the Placenta During Cesarean Section on the Amount of Bleeding Into the Abdominal Cavity.
Study Overview
Status
Conditions
Detailed Description
In this study the investigators will recruit 200 pregnant women; 100 women in the study group and 100 women in the control group. The women will be randomly allocated in two groups. The odd numbered women will be in the study group and even numbered women will be in the control group.
The investigators will perform cesarean section according to the obstetrical indications. Lower segment uterine incision will be used during the cesarean section. After the delivery of the fetus two distinct procedures will be used in the control and study groups.
In the control group, the uterus will be left in the abdominal cavity and the placenta will be manually removed with uterine massage as soon as possible. After removal of the placenta, the uterus will be dragged out of the abdominal cavity. The cesarean incision will be sutured with no. 1 Vicryl ®. Uterus will be replaced in the abdominal cavity. Intra-abdominal cavity will be cleaned by aspirator and mounted-gauze tampon. The weight of the placenta will be measured. The weight of the gauze tampons will be measured with gravimetric method before and after use.
In the study group, at first, the uterus will be dragged out of the abdominal cavity, prior to removal of the placenta. The placenta will be manually removed with uterine massage as soon as possible. The cesarean incision will be sutured with no. 1 Vicryl ®. Uterus will be replaced in the abdominal cavity. Intra-abdominal cavity will be cleaned by aspirator and mounted-gauze tampon. The weight of the placenta will be measured. The weight of the gauze tampons will be measured with gravimetric method before and after use.
In both groups, the abdominal cavity will be closed as appropriate. The vital signs (blood pressure and heart rate) will be monitored. Postoperative blood samples for complete blood count (CBC) will be taken 24 hours after the operation. Bowel movements will be assessed every 6 hours by a stethoscope. Time of the first flatulence will be recorded. Visual Analog Scoring (VAS) survey validated in Turkey will be performed in the postoperative 1. and 2. days. The type and amount of postoperative analgesics will be recorded. The body temperature will regularly be assessed in the first 24. and 48. hours. The presence of fever will be recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Trnc
-
Mersin, Trnc, Turkey, 10
- Near East University, Obstetrics and Gynecology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women undergoing cesarean section according to the obstetrical indications.
Exclusion Criteria:
- Uterine anomalies such as didelphys, bicornis, etc.
- Placental adhesion anomalies
- Postpartum uterine hemorrhage (>500 ml)
- Polyhydramnios
- Uterine atony
- Women with known coagulation disorders
- Abnormal preoperative APTT, PT and INR
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Intra-abdominal removal of the placenta
The uterus will be left in the abdominal cavity and the placenta will be manually removed with uterine massage as soon as possible.
After removal of the placenta, the uterus will be dragged out of the abdominal cavity.
The cesarean incision will be sutured with no. 1 Vicryl ®.
Uterus will be replaced in the abdominal cavity.
Intra-abdominal cavity will be cleaned by aspirator and mounted-gauze tampon.
The weight of the placenta will be measured.
The weight of the gauze tampons will be measured with gravimetric method before and after use.
|
|
|
Experimental: Extra-abdominal removal of the placenta
No drug or device is used. The uterus will be dragged out of the abdominal cavity, prior to removal of the placenta. The placenta will be manually removed with uterine massage as soon as possible. The cesarean section will be completed as described in "No intervention" group. |
The uterus will be dragged out of the abdominal cavity, prior to removal of the placenta.
The placenta will be manually removed extra-abdominally, with uterine massage as soon as possible.
The cesarean incision will be sutured with no. 1 Vicryl ®.
Uterus will be replaced in the abdominal cavity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The amount of aspirated fluid during the cesarean section
Time Frame: 3 months
|
The amount of aspirated fluid during the cesarean section in mililiters
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between preoperative and postoperative hemoglobin levels
Time Frame: 3 months
|
Difference between preoperative and postoperative hemoglobin levels expressed as g/dL
|
3 months
|
|
The weight of the gauze before and after use in cesarean section
Time Frame: 3 months
|
The weight of the gauze before and after use in cesarean section, described in miligrams
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Baris Kaya, MD, Near East University, Obstetrics and Gynecology, Lefkosa-TRNC, Mersin 10, Turkey
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- KAYA-2013-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on the Influence of Intra- vs Extra-abdominal Removal of Placenta
-
University of Kansas Medical CenterRecruitingFemoral Neck Fractures | Distal Radius Fractures | Femoral Shaft Fracture | Intertrochanteric Fractures | Patella Fracture | Lisfranc Injuries | Distal Femur Fracture | Calcaneus Fractures | Clavicle Fractures | Proximal Humerus Fractures | Tibial Pilon Fracture | Talar Head, Neck, Body, or Process Fractures | Isolated... and other conditionsUnited States
Clinical Trials on Extra-abdominal removal of the placenta
-
Casa di Cura Dott. PederzoliUniversity of PadovaRecruitingPancreas Fistula Abdominal DrainsItaly
-
Kasr El Aini HospitalCompleted
-
Maisonneuve-Rosemont HospitalCompleted
-
Sequana Medical N.V.CompletedRefractory or Recurrent AscitesSpain, United Kingdom, Italy, France, Austria
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruiting
-
Meshalkin Research Institute of Pathology of CirculationNot yet recruitingFrequency of Embolic Complications | Frequency of Ischemic ComplicationsRussian Federation
-
Kasr El Aini HospitalRecruitingPregnancy | Apgar Score | Tourniquets | Placenta Accrete SpectrumEgypt
-
University of JordanCompletedUrinary RetentionJordan
-
Beijing Tiantan HospitalUnknownLanguage | AVM - Cerebral Arteriovenous MalformationChina
-
University of PrimorskaFotona d.o.o.Completed